SCHEMBL18952140

SCHEMBL18952140

Cc1ccc(S(=O)(=O)n2ccc(Br)c2)c(F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NMT1 P30419 1/20 0.36
LMNA P02545 2/20 0.36
RAPGEF4 Q8WZA2 1/20 0.33
KAT6A Q92794 2/20 0.33
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
POLB P06746 1/20 0.33
HPGD P15428 1/20 0.33
ALOX12 P18054 1/20 0.33
GFER P55789 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
TP53 P04637 1/20 0.32
MAPK10 P53779 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20535101 0.85 RAPGEF4 (0.47) LMNARAPGEF4ALDH1A1SMN1; SMN2MAPT
SCHEMBL18952168 0.80 CA1 (0.53) LMNARAPGEF4KAT6AALDH1A1SMN1; SMN2
SCHEMBL15974991 0.74 CA1 (0.59) RAPGEF4ALDH1A1MAPTPOLBCA1
SCHEMBL28510674 0.70 HTT (0.38) LMNARAPGEF4ALDH1A1SMN1; SMN2KMT2A
SCHEMBL4132176 0.69 CNR2 (0.43) RAPGEF4KAT6AMEN1KMT2ATP53
SCHEMBL25873556 0.69 MEN1 (0.46) NMT1LMNARAPGEF4ALDH1A1SMN1; SMN2
SCHEMBL14700843 0.69 GRM4 (0.70)
SCHEMBL11995566 0.68 PTGS2 (0.46) KAT6AALDH1A1L3MBTL1CA1CA2
SCHEMBL21875094 0.68 HDAC1 (0.42) KAT6ASMN1; SMN2L3MBTL1
SCHEMBL14529330 0.68 CD44 (0.34) LMNARAPGEF4MAPK10NPSR1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3362451-A1 INHIBITORS OF INFLUENZA VIRUS REPLICATION, APPLICATION METHODS AND USES THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2018-08-22 EP disclosed
WO-2017097234-A1 INHIBITORS OF INFLUENZA VIRUS REPLICATION, APPLICATION METHODS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2017-06-15 WO disclosed